Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Infusive Technologies

2004 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of proprietary and patented multi-chamber, sequential, dose syringe technology. The company develops syringe technology developed under its product name "ChaSyr" which allows for the sequential administration of two separate intravenous (IV) medications with a single syringe, replacing multiple syringes with just one.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 620 South Main Street
  • Bountiful, UT 84010
  • United States

Infusive Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Infusive Technologies‘s full profile, request access.

Request full access to PitchBook

Infusive Technologies Executive Team (2)

Name Title Board
Seat
Contact
Info
Gale Thorne Jr. President & Chief Operating Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »